As of 2026-05-07, the Relative Valuation of MacroGenics Inc (MGNX) is (18.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.15 USD, the upside of MacroGenics Inc based on Relative Valuation is -685.1%.
The range of the Relative Valuation is (14.30) - (22.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 18.9x | 16.5x |
| Forward P/E multiples | 11.1x - 18.9x | 14.9x |
| Fair Price | (14.30) - (22.19) | (18.43) |
| Upside | -554.0% - -804.4% | -685.1% |
| Date | P/E |
| 2026-05-01 | -2.67 |
| 2026-04-30 | -2.62 |
| 2026-04-29 | -2.50 |
| 2026-04-28 | -2.56 |
| 2026-04-27 | -2.60 |
| 2026-04-24 | -2.72 |
| 2026-04-23 | -2.71 |
| 2026-04-22 | -2.91 |
| 2026-04-21 | -2.96 |
| 2026-04-20 | -2.96 |
| 2026-04-17 | -2.95 |
| 2026-04-16 | -2.90 |
| 2026-04-15 | -3.00 |
| 2026-04-14 | -2.97 |
| 2026-04-13 | -2.96 |
| 2026-04-10 | -3.07 |
| 2026-04-09 | -2.93 |
| 2026-04-08 | -2.94 |
| 2026-04-07 | -2.85 |
| 2026-04-06 | -2.71 |
| 2026-04-02 | -2.61 |
| 2026-04-01 | -2.47 |
| 2026-03-31 | -2.46 |
| 2026-03-30 | -2.35 |
| 2026-03-27 | -2.50 |
| 2026-03-26 | -2.71 |
| 2026-03-25 | -2.70 |
| 2026-03-24 | -2.33 |
| 2026-03-23 | -2.49 |
| 2026-03-20 | -2.44 |
| 2026-03-19 | -2.47 |
| 2026-03-18 | -2.54 |
| 2026-03-17 | -2.62 |
| 2026-03-16 | -2.64 |
| 2026-03-13 | -2.56 |
| 2026-03-12 | -2.66 |
| 2026-03-11 | -2.84 |
| 2026-03-10 | -2.92 |
| 2026-03-09 | -2.01 |
| 2026-03-06 | -1.90 |
| 2026-03-05 | -1.82 |
| 2026-03-04 | -1.77 |
| 2026-03-03 | -1.62 |
| 2026-03-02 | -1.65 |
| 2026-02-27 | -1.70 |
| 2026-02-26 | -1.69 |
| 2026-02-25 | -1.64 |
| 2026-02-24 | -1.47 |
| 2026-02-23 | -1.49 |
| 2026-02-20 | -1.45 |